Next Article in Journal
Long-Term Risk Trajectories of Diabetes Differ After Direct-Acting Antiviral and Interferon Therapy in Chronic Hepatitis C: A Real-World Cohort Study
Previous Article in Journal
Optic Flow-Induced Postural and Neuromuscular Responses in Individuals with Type 2 Diabetes over 12 Months: Relationship with Physical Activity Behaviour
Previous Article in Special Issue
Intracellular Vesicle Transport Impairment as a Candidate Systems-Level Bottleneck in Chronic Diabetic Foot Ulcers: Network Medicine Identifies KIF13A as a Potential Therapeutic Vulnerability
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Review

Mediterranean Dietary Pattern in Type 2 Diabetes Management: Pathways and Clinical Evidence

by
Dubravka Majić Milotić
1,†,
Tomislav Bulum
1,2,* and
Kristijan Peroš
1,†
1
Department of Diabetes and Endocrinology, Vuk Vrhovac University Clinic for Diabetes, Endocrinology and Metabolic Diseases, Merkur University Hospital, 10000 Zagreb, Croatia
2
School of Medicine, University of Zagreb, 10000 Zagreb, Croatia
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Biomedicines 2026, 14(6), 1350; https://doi.org/10.3390/biomedicines14061350 (registering DOI)
Submission received: 9 May 2026 / Revised: 6 June 2026 / Accepted: 8 June 2026 / Published: 15 June 2026
(This article belongs to the Special Issue Diabetes: Comorbidities, Therapeutics and Insights (3rd Edition))

Abstract

The Mediterranean diet (MedDiet) has emerged as a promising dietary strategy for the prevention and management of type 2 diabetes mellitus (T2DM). This narrative review provides a comprehensive synthesis linking the biological pathways of the MedDiet with established clinical evidence. Adherence to this traditional dietary pattern—characterized by a high intake of fiber, complex carbohydrates, antioxidants, and healthy fats—has demonstrated significant benefits in terms of glycemic control, enhanced insulin sensitivity, and overall metabolic health. Mechanistically, the review explains how the MedDiet improves health by modulating key physiological processes, including anti-inflammatory and antioxidant pathways, the regulation of branched-chain amino acid metabolism, the enhancement of short-chain fatty acid production via gut microbiota modulation, and upregulated incretin effects. Importantly, this review explains how the MedDiet complements modern medications, including glucagon-like peptide-1 (GLP-1) receptor agonists and sodium–glucose cotransporter-2 (SGLT-2) inhibitors. By integrating molecular mechanisms with human clinical outcomes, this narrative review addresses multiple aspects of the MedDiet in both the prevention and management of T2DM including glycemic control, weight management, and cardiovascular risk reduction, rendering it a valuable dietary strategy for both the prevention and treatment of this chronic condition.
Keywords: Mediterranean diet; type 2 diabetes; plant-based foods; healthy fats; omega-3 fatty acids Mediterranean diet; type 2 diabetes; plant-based foods; healthy fats; omega-3 fatty acids

Share and Cite

MDPI and ACS Style

Majić Milotić, D.; Bulum, T.; Peroš, K. Mediterranean Dietary Pattern in Type 2 Diabetes Management: Pathways and Clinical Evidence. Biomedicines 2026, 14, 1350. https://doi.org/10.3390/biomedicines14061350

AMA Style

Majić Milotić D, Bulum T, Peroš K. Mediterranean Dietary Pattern in Type 2 Diabetes Management: Pathways and Clinical Evidence. Biomedicines. 2026; 14(6):1350. https://doi.org/10.3390/biomedicines14061350

Chicago/Turabian Style

Majić Milotić, Dubravka, Tomislav Bulum, and Kristijan Peroš. 2026. "Mediterranean Dietary Pattern in Type 2 Diabetes Management: Pathways and Clinical Evidence" Biomedicines 14, no. 6: 1350. https://doi.org/10.3390/biomedicines14061350

APA Style

Majić Milotić, D., Bulum, T., & Peroš, K. (2026). Mediterranean Dietary Pattern in Type 2 Diabetes Management: Pathways and Clinical Evidence. Biomedicines, 14(6), 1350. https://doi.org/10.3390/biomedicines14061350

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop